Stable Gene Targeting in Human Cells Using Single-Strand Oligonucleotides with Modified Bases

Citations Over TimeTop 22% of 2012 papers

Abstract

Recent advances allow multiplexed genome engineering in E. coli, employing easily designed oligonucleotides to edit multiple loci simultaneously. A similar technology in human cells would greatly expedite functional genomics, both by enhancing our ability to test how individual variants such as single nucleotide polymorphisms (SNPs) are related to specific phenotypes, and potentially allowing simultaneous mutation of multiple loci. However, oligo-mediated targeting of human cells is currently limited by low targeting efficiencies and low survival of modified cells. Using a HeLa-based EGFP-rescue reporter system we show that use of modified base analogs can increase targeting efficiency, in part by avoiding the mismatch repair machinery. We investigate the effects of oligonucleotide toxicity and find a strong correlation between the number of phosphorothioate bonds and toxicity. Stably EGFP-corrected cells were generated at a frequency of ~0.05% with an optimized oligonucleotide design combining modified bases and reduced number of phosphorothioate bonds. We provide evidence from comparative RNA-seq analysis suggesting cellular immunity induced by the oligonucleotides might contribute to the low viability of oligo-corrected cells. Further optimization of this method should allow rapid and scalable genome engineering in human cells.

Related Papers

• → The effects of fluoride on cell growth and protein synthesis in HeLa cells.(1985)
• Effect of apoptosis rate on cervical carcinoma cell line HeLa by 4-HPR and Cisplatin(2008)
• Research of the apoptosis of TRAIL on cervical cancer HeLa cells(2008)
• Effects of iNOS inhibitor 1400 W on the cervical cancer cell line HeLa(2009)
• Inhibition of SAHA on HeLa and p53 Knock-down HeLa-E3 Cells Proliferation(2009)